Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 17.87 M19.77 M19.55 M20.66 M19.7 M19.25 M 79.16 M Research & development —————— — Operating income 7.68 M-51 K6.78 M7.57 M11.02 M-2.27 M 23.1 M Non-Operating Income, Total -2.56 M2.04 M-820 K-7.51 M-1.19 M-906 K -10.42 M Interest expense, net of interest capitalized 1.77 M1.94 M1.09 M949 K1.66 M1.62 M 5.31 M Non-Operating Income, excl. Interest Expenses -2.25 M2.26 M-573 K-7.54 M-1.1 M-574 K -9.78 M Unusual income/expense -303 K-217 K-247 K29 K-92 K-332 K -642 K Pretax income 5.13 M1.99 M5.96 M66 K9.83 M-3.17 M 12.68 M Equity in earnings —————— — Taxes 227 K-1.27 M-7.3 M3.91 M991 K-2.21 M -4.61 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 4.9 M3.26 M13.25 M-3.84 M8.84 M-963 K 17.29 M Discontinued operations —————— — Net income 4.9 M3.26 M13.25 M-3.84 M8.84 M-963 K 17.29 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 4.9 M3.26 M13.25 M-3.84 M8.84 M-963 K 17.29 M Basic earnings per share (Basic EPS) 0.670.441.78-0.521.18-0.13 2.31 Diluted earnings per share (Diluted EPS) 0.660.441.78-0.531.17-0.13 2.29 Average basic shares outstanding 7.36 M7.45 M7.45 M7.42 M7.48 M7.54 M — Diluted shares outstanding 7.45 M7.45 M7.45 M7.48 M7.55 M7.54 M — EBITDA -19.47 M-27.11 M-23.21 M-27.5 M-19.89 M-41.95 M -112.56 M EBIT -26.26 M-33.2 M-29.41 M-33.7 M-25.4 M-48.06 M -136.57 M Cost of revenue 55.92 M61.41 M66.64 M54.75 M48.48 M57.11 M 226.99 M Other cost of goods sold 3 M1.3 M2.7 M-14 K—— — Depreciation & amortization (cash flow) 6.79 M6.09 M6.19 M6.2 M5.51 M6.11 M 24.01 M